β-Amyloid (NAB228) Antibody sc-32277 from Santa Cruz Biotechnology, Inc.

Product Specs
Itemβ-Amyloid (NAB228) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-32277
Antibody TypePrimary Antibodies
NCBI Gene AliasesCTFgamma, CVAP, AAA, ABETA, AD1, PN-II, preA4, PN2, ABPP, APPI, alpha-sAPP
CloneNAB228
Quantity200 µg/ml
Reactivityhuman
ApplicationsWB, IP, IF, IHC(P)
Conjugate/TagUnconjugated
Hostmouse
ClonalityMonoclonal
FormatPurified
NCBI Full Gene Nameamyloid beta precursor protein
Targetbeta-Amyloid
IsotypeIgG2a

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Correlation of brain tissue volume loss with inflammatory biomarkers IL1β, P-tau, T-tau, and NLPR3 in the aging cognitively impaired populationFrontiers in Aging NeuroscienceJuly 23, 2024Kyung Mi Lee, Sang Tae Kim, Yunan Tian, Sue Min Jung, Yunjung Chang, Hak Young Rhee, Soonchan Park, Chang-Woo Ryu, Woo-In Lee, Eui Jong Kim, et al.Novus Biologicals). Other primary antibodies used for ICC (immunocytochemistry analysis) were mAβ (sc-32277, Santa Cruz), T-tau (sc-32274, Santa Cruz), P-tau (sc-32275, Santa Cruz), and IL1β (sc-32294, Santa Cruz

(2) Memophenol(TM) Prevents Amyloid-β Deposition and Attenuates Inflammation and Oxidative Stress in the Brain of an Alzheimer's Disease RatInternational journal of molecular sciencesApril 8, 2023Impellizzeri D, Tomasello M, Cordaro M, D'Amico R, Fusco R, Abdelhameed AS, Wenzel U, Siracusa R, Calabrese V, Cuzzocrea S, et al.(Santa Cruz Biotechnology, sc-136960), anti-p-Tau (Santa Cruz Biotechnology, sc-32275), anti-APP (Santa Cruz Biotechnology, sc-32277), anti-GFAP (Cell Signaling Technology, Danvers, MA, USA), and anti-Iba1 (Santa Cruz Biotechnology,

(3) [(18)F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human dataJournal of neuroinflammationMarch 11, 2023Ballweg A, Klaus C, Vogler L, Katzdobler S, Wind K, Zatcepin A, Ziegler SI, Secgin B, Eckenweber F, Bohr B, et al.anti-Iba1 1:500 (234004, Synaptic Systems, Göttingen, Germany), mouse anti-β-amyloid 1:500 (NAB228, sc-32277, Santa Cruz Biotechnology, Texas, USA) and goat anti-TPH2 1:500 (ab121013, Abcam, Cambridge, UK), diluted

(4) Mechanism of Action of Natural Compounds in Peripheral Multiorgan Dysfunction and Hippocampal Neuroinflammation Induced by SepsisAntioxidants (Basel, Switzerland)March 3, 2023D'Amico R, Tomasello M, Impellizzeri D, Cordaro M, Siracusa R, Interdonato L, Abdelhameed AS, Fusco R, Calabrese V, Cuzzocrea S, et al.USA" Anti-p-Tau,"Santa Cruz Biotechnology, sc-32275, Milan, Italy" Anti-APP,"Santa Cruz Biotechnology, sc-32277, Milan, Italy" Anti-occludin,"Santa Cruz Biotechnology, sc-133255, Milan, Italy" Anti-ZO,"Santa Cruz Biotechnology

(5) Beneficial Effect of ACI-24 Vaccination on Aβ Plaque Pathology and Microglial Phenotypes in an Amyloidosis Mouse ModelCellsDecember 24, 2022Rudan Njavro J, Vukicevic M, Fiorini E, Dinkel L, Müller SA, Berghofer A, Bordier C, Kozlov S, Halle A, Buschmann K, et al.analysed by confocal microscopy. Primary antibodies used: Aβ 3552 (0.74 µg/mL) [49], Aβ NAB228 (1:500, sc-32277, Santa Cruz Biotechnology, Heidelberg, Germany) [10], BACE1 (1:400, ab108394, Abcam, Cambridge, UK),

(6) An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer's diseaseNat AgingJuly 1, 2022Jiang Y, Zhou X, Wong HY, Ouyang L, Ip FCF, Chau VMN, Lau SF, Wu W, Wong DYK, Seo H, et al.solution. We then incubated the sections with a mouse anti-human Aβ antibody (1:500 dilution; clone NAB228, SC-32277, Santa Cruz Biotechnology) overnight at 4 °C. After washing, we incubated the sections with horseradish

(7) β-secretase inhibition prevents structural spine plasticity deficits in App (NL-G-F) miceFrontiers in aging neuroscienceJanuary 1, 2022Blume T, Filser S, Sgobio C, Peters F, Neumann U, Shimshek D, Saito T, Saido TC, Brendel M, Herms J.

(8) Key Mechanisms and Potential Implications of Hericium erinaceus in NLRP3 Inflammasome Activation by Reactive Oxygen Species during Alzheimer's DiseaseAntioxidants (Basel, Switzerland)October 22, 2021Cordaro M, Salinaro AT, Siracusa R, D'Amico R, Impellizzeri D, Scuto M, Ontario ML, Cuzzocrea S, Di Paola R, Fusco R, et al.(Santa Cruz Biotechnology, sc-7271), anti-p-Tau (Santa Cruz Biotechnology, sc-32275), or anti-APP (Santa Cruz Biotechnology, sc-32277), anti-NLRP3 (Cell Signaling Technology, Danvers, MA, USA), anti-ASC (Santa Cruz Biotechnology, sc-271054),

(9) Casein Kinase 2 dependent phosphorylation of eIF4B regulates BACE1 expression in Alzheimer''s diseaseCell death & diseaseAugust 4, 2021Bettegazzi B, Sebastian Monasor L, Bellani S, Codazzi F, Restelli LM, Colombo AV, Deigendesch N, Frank S, Saito T, Saido TC, et al.

(10) Hidrox(®) Roles in Neuroprotection: Biochemical Links between Traumatic Brain Injury and Alzheimer's DiseaseAntioxidants (Basel, Switzerland)May 20, 2021Cordaro M, Trovato Salinaro A, Siracusa R, D'Amico R, Impellizzeri D, Scuto M, Ontario ML, Crea R, Cuzzocrea S, Di Paola R, et al.sc-136970), or anti-p-Tau (Santa Cruz Biotechnology, sc-32275). or anti-APP (Santa Cruz Biotechnology, sc-32277) were mixed in a 5% w/v nonfat dried milk solution and were incubated at 4 ◦ C, overnight. Afterwards,

(11) Multimodal in vivo and postmortem assessments of tau in Lewy body disordersNeurobiology of agingDecember 1, 2020Coughlin DG, Phillips JS, Roll E, Peterson C, Lobrovich R, Rascovsky K, Ungrady M, Wolk DA, Das S, Weintraub D, et al.

(12) Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse modelseLifeJune 8, 2020Sebastian Monasor L, Müller SA, Colombo AV, Tanrioever G, König J, Roth S, Liesz A, Berghofer A, Piechotta A, Prestel M, et al.following primary antibodies: IBA1 (1:500, 019–19741,Wako), IBA1 (1:500, ab5076, Abcam), NAB228 (1:2000, sc-32277, Santa Cruz), CD68 (1:500, MCA1957GA, Bio-Rad), TREM2 (1:50, AF1729, R and DSystems), APP-Y188 (1:2000,

(13) Tau deletion reduces plaque-associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's diseaseThe EMBO journalDecember 2, 2019Peters F, Salihoglu H, Pratsch K, Herzog E, Pigoni M, Sgobio C, Lichtenthaler SF, Neumann U, Herms J.ab32136, Abcam, 1:500), IBA1 (rabbit polyclonal, 019‐19741, Wako, 1:500), NAB228 (mouse monoclonal, sc‐32277, Santa Cruz, 1:500), Ab126468 (rabbit polyclonal, Abcam, 1:500) and ubiquitin (rabbit polyclonal, ab7780,

(14) Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse ModelJournal of nuclear medicine : official publication, Society of Nuclear MedicineDecember 1, 2019Sacher C, Blume T, Beyer L, Peters F, Eckenweber F, Sgobio C, Deussing M, Albert NL, Unterrainer M, Lindner S, et al.

(15) Cognitive and Pathological Influences of Tau Pathology in Lewy Body DisordersAnnals of neurologyFebruary 1, 2019Coughlin D, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA, Akhtar RS, Hurtig HI, et al.

(16) Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating propertyPloS oneJuly 27, 2010Sepulveda FJ, Parodi J, Peoples RW, Opazo C, Aguayo LG.

Be the First to Write a Review!

β-Amyloid (NAB228) Antibody

β-Amyloid (NAB228) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (16)

Reviews

β-Amyloid (NAB228) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map